MCED Testing Enters New Diagnostic Realms

Elie Dolgin • August 4, 2023

Real-world performance data and trial results in symptomatic individuals continue to validate the promise of screening for multiple cancers with a single blood draw. However, some worry about the performance of GRAIL's commercially available multicancer early detection test in certain high-risk groups that were not the focus of early clinical development efforts.

Continue reading at Cancer Discovery.

Blue and gold fibrous texture in the shape of brain
By Elie Dolgin June 30, 2025
AI and real-time neural feedback could transform treatments.
Damaged 15th century painting by the Master of the Prado Adoration of the Magi
By Elie Dolgin June 12, 2025
Pixels meet paint, as a digital “mask” conceals damage on a 15th-century painting.